Physician profile
Michael C White
NPI 1255319349
$1,949.68
in general payments reported to CMS, 2019-2025
17 companies · $444 in 2025
The $444 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $134 · 2020: $67.25 · 2021: $229 · 2022: $194 · 2023: $388 · 2024: $493 · 2025: $444.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,046 · Education: $279.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,045.62 |
| Education | $278.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $404.99 | 2021-2025 | Tremfya |
| Davol INC. | $302.26 | 2019-2023 | Phasix Mesh |
| Novartis Pharmaceuticals Corporation | $214.98 | 2020-2025 | |
| Pfizer INC. | $207.29 | 2019-2024 | |
| Genzyme Corporation | $147.42 | 2021-2025 | |
| Histosonics, INC. | $142.30 | 2024 | |
| Incyte Corporation | $95.71 | 2022-2025 | Opzelura |
| Regeneron Healthcare Solutions, INC. | $91.50 | 2021-2025 | Dupixent |
| Arcutis Biotherapeutics, INC. | $85.65 | 2024-2025 | Zoryve |
| Amgen INC. | $51.59 | 2024-2025 | Otezla, Otezla |
| Abbvie INC. | $45.64 | 2022-2024 | |
| Sun Pharmaceutical Industries INC. | $38.46 | 2023-2025 | Blu-U, Odomzo |
| Galderma Laboratories, L.P. | $33.92 | 2025 | Nemluvio |
| E.R. Squibb & Sons, L.L.C. | $33.63 | 2023-2025 | Sotyktu |
| Verrica Pharmaceuticals INC. | $19.84 | 2025 | Ycanth |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $19.51 | 2022 | |
| Leo Pharma INC. | $14.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael White listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.